REFSYN

Puducherry, India
Custom synthesis, contract research, and supply of API impurities and metabolites in India.

About REFSYN

REFSYN is a Healthcare company based in Puducherry (India). Custom synthesis, contract research, and supply of API impurities and metabolites in India. It operates in the Healthcare and Chemicals & Materials sectors. Its Indian entity Refsyn Biosciences Private Limited reported revenue of β‚Ή23.7 Lakh. REFSYN offers products and services including API Impurities and Metabolites. Its focus areas include Pharmaceuticals, API Manufacturing, Impurities and Metabolites and Agriculture.

Company details

REFSYN BIOSCIENCES was established in 2012 in Puducherry, India, as an ISO 9001:2015 certified custom synthesis and contract research organization. It is recognized for manufacturing and exporting API impurities, drug metabolites, and certified reference standards to support pharmaceutical, biomedical, biotechnology, and agrochemical sectors. Products are intended solely for research and analytical purposes, with services including technology transfer and analytical support. The company operates under government registration and focuses on providing standards like USP, EP, and JP for industry needs.

  • Headquarters Puducherry, India
  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website refsyn.com
  • Social X YouTube
  • Legal Name Refsyn Biosciences Pvt Ltd
  • Date of Incorporation 10 Jan, 2012
  • Jurisdiction Puducherry, India
Key Metrics
  • Annual Revenue
    ₹23.7 Lakh

    FY 2025 · +30% YoY

  • Net Loss
    -₹11.9 Lakh

    FY 2025 · -50% margin

  • EBITDA
    -₹10.9 Lakh

    FY 2025 · -46% margin

Products & Services of REFSYN

REFSYN offers a comprehensive portfolio of products and services, including API Impurities and Metabolites.

API Impurities
Pharmaceutical Standards

API impurities are manufactured and supplied for research and analytical applications in the pharmaceutical sector

Metabolites
Drug Metabolites

Drug metabolites are provided as standards for analytical use in pharmaceutical and biomedical research

Apps and channels of REFSYN

its YouTube channel REFSYN BIOSCIENCES PRIVATE LIMITED has 33 subscribers and 10 videos.

REFSYN BIOSCIENCES PRIVATE LIMITED
YouTube 33 subscribers 10 videos Education
Open channel

Videos from REFSYN

The most watched videos on REFSYN's YouTube channel, REFSYN BIOSCIENCES PRIVATE LIMITED (33 subscribers). Click a video to play it here.

Farewell Party for Msc Project (2012-13) Students at REFSYN Puducherry.
1.7K views
BWASCollege Kallakurichi at REFSYN Puducherry
1.1K views
Final Year MSc Students Project Review at REFSYN Biosciences Pvt Ltd., Puducherry
862 views
HPLC and PCR Demo for Achariya Arts and Science College at REFSYN ,Puducherry
763 views

More on REFSYN BIOSCIENCES PRIVATE LIMITED.

Board of directors of Refsyn Biosciences Private Limited (REFSYN)

Refsyn Biosciences Private Limited is the primary company behind REFSYN. The board of Refsyn Biosciences Private Limited currently have 2 directors; the longest-serving is Geetha Subramanian, appointed in 2012. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Geetha Subramanian
DIN 05164533
Director10 Jan 201214 yrs 10 moRefsyn Biosciences Private Limited
Arun Mohambaram
DIN 08752892
Director03 Jun 20206 yrs 5 moRefsyn Biosciences Private Limited

Financials of REFSYN

Figures of Refsyn Biosciences Private Limited, the primary company behind REFSYN, for FY 2025. Revenue was ₹23.7 Lakh (+30% year on year). Net loss was -₹11.9 Lakh (-50% margin). EBITDA was -₹10.9 Lakh (-46% margin). Revenue has grown at a compounded annual rate of -23% over three years and -7% over five years.

  • ₹23.7 LakhRevenue · FY 2025 · +30% YoY
  • -₹11.9 LakhNet loss · -50% margin
  • -₹10.9 LakhEBITDA · -46% margin
  • ₹1 LakhPaid-up capital
  • -23%Revenue CAGR, 3 years
  • -7%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Refsyn Biosciences Private Limited are on its company page.

Premium access

Detailed financial statements for REFSYN

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of REFSYN

The website of REFSYN (refsyn.com) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▼ 19.9% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about REFSYN

REFSYN is headquartered in Puducherry, India. It is registered at Puducherry, Puducherry, India.

The primary company behind REFSYN, Refsyn Biosciences Private Limited, reported revenue of β‚Ή23.7 Lakh for FY 2025, up 30% year on year.

REFSYN BIOSCIENCES was established in 2012 in Puducherry, India, as an ISO 9001:2015 certified custom synthesis and contract research organization. It is recognized for manufacturing and exporting API impurities, drug metabolites, and certified reference standards to support pharmaceutical, biomedical, biotechnology, and agrochemical sectors. Products are intended solely for research and analytical purposes, with services including technology transfer and analytical support. The company operates under government registration and focuses on providing standards like USP, EP, and JP for industry needs.

REFSYN offers API Impurities and Metabolites.

REFSYN operates through Refsyn Biosciences Private Limited.

The legal entities of REFSYN currently have 2 directors, including Arun Mohambaram, Geetha Subramanian.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available